Published 20 December 2004. doi:10.1084/jem.20041306
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 200, Number 12, 1689-1695
Role of Dok-1 and Dok-2 in Leukemia Suppression
Masaru Niki1,2,
Antonio Di Cristofano1,2,
Mingming Zhao3,
Hiroaki Honda4,
Hisamaru Hirai5,
Linda Van Aelst3,
Carlos Cordon-Cardo2, and
Pier Paolo Pandolfi1,2
1 Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10021
2 Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021
3 Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724
4 Department of Developmental Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima 734-8553, Japan
5 Department of Hematology & Oncology, Graduate School of Medicine, University of Tokyo, Tokyo 113-8655, Japan
Address correspondence to Pier Paolo Pandolfi, Cancer Biology and Genetics Program and Dept. of Pathology, Box 110, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021. Phone: (212) 639-6168; Fax: (212) 717-3102; email: p-pandolfi{at}ski.mskcc.org
Chronic myelogenous leukemia (CML) is characterized by the presence of the chimeric p210bcr/abl oncoprotein that shows elevated and constitutive protein tyrosine kinase activity relative to the normal c-abl tyrosine kinase. Although several p210bcr/abl substrates have been identified, their relevance in the pathogenesis of the disease is unclear. We have identified a family of proteins, Dok (downstream of tyrosine kinase), coexpressed in hematopoietic progenitor cells. Members of this family such as p62dok (Dok-1) and p56dok-2 (Dok-2) associate with the p120 rasGTPase-activating protein (rasGAP) upon phosphorylation by p210bcr/abl as well as receptor and nonreceptor tyrosine kinases. Here, we report the generation and characterization of single and double Dok-1 or Dok-2 knockout (KO) mutants. Single KO mice displayed normal steady-state hematopoiesis. By contrast, concomitant Dok-1 and Dok-2 inactivation resulted in aberrant hemopoiesis and Ras/MAP kinase activation. Strikingly, all Dok-1/Dok-2 double KO mutants spontaneously developed transplantable CML-like myeloproliferative disease due to increased cellular proliferation and reduced apoptosis. Furthermore, Dok-1 or Dok-2 inactivation markedly accelerated leukemia and blastic crisis onset in Tec-p210bcr/abl transgenic mice known to develop, after long latency, a myeloproliferative disorder resembling human CML. These findings unravel the critical and unexpected role of Dok-1 and Dok-2 in tumor suppression and control of the hematopoietic compartment homeostasis.
Key Words: cell proliferation apoptosis knockout CML leukemogenesis signal transduction
A. Di Cristofano's present address is Human Genetics Program, Fox Chase Cancer Center, Philadelphia, PA 19111.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Miyazaki, K., Yamasaki, N., Oda, H., Kuwata, T., Kanno, Y., Miyazaki, M., Komeno, Y., Kitaura, J., Honda, Z.-i., Warming, S., Jenkins, N. A., Copeland, N. G., Kitamura, T., Nakamura, T., Honda, H.
(2009). Enhanced expression of p210BCR/ABL and aberrant expression of Zfp423/ZNF423 induce blast crisis of chronic myelogenous leukemia. Blood
113: 4702-4710
[Abstract]
[Full Text]
-
Inoue, A., Yasuda, T., Yamamoto, T., Yamanashi, Y.
(2007). Dok-1 is a Positive Regulator of IL-4 Signalling and IgE Response. J Biochem
142: 257-263
[Abstract]
[Full Text]
-
Ng, C.-H., Xu, S., Lam, K.-P.
(2007). Dok-3 plays a nonredundant role in negative regulation of B-cell activation. Blood
110: 259-266
[Abstract]
[Full Text]
-
Hatjiharissi, E., Ngo, H., Leontovich, A. A., Leleu, X., Timm, M., Melhem, M., George, D., Lu, G., Ghobrial, J., Alsayed, Y., Zeismer, S., Cabanela, M., Nehme, A., Jia, X., Moreau, A. S., Treon, S. P., Fonseca, R., Gertz, M. A., Anderson, K. C., Witzig, T. E., Ghobrial, I. M.
(2007). Proteomic Analysis of Waldenstrom Macroglobulinemia. Cancer Res.
67: 3777-3784
[Abstract]
[Full Text]
-
Yasuda, T., Bundo, K., Hino, A., Honda, K., Inoue, A., Shirakata, M., Osawa, M., Tamura, T., Nariuchi, H., Oda, H., Yamamoto, T., Yamanashi, Y.
(2007). Dok-1 and Dok-2 are negative regulators of T cell receptor signaling. Int Immunol
19: 487-495
[Abstract]
[Full Text]
-
Dong, S., Corre, B., Foulon, E., Dufour, E., Veillette, A., Acuto, O., Michel, F.
(2006). T cell receptor for antigen induces linker for activation of T cell-dependent activation of a negative signaling complex involving Dok-2, SHIP-1, and Grb-2. JEM
203: 2509-2518
[Abstract]
[Full Text]
-
Niu, Y., Roy, F., Saltel, F., Andrieu-Soler, C., Dong, W., Chantegrel, A.-L., Accardi, R., Thepot, A., Foiselle, N., Tommasino, M., Jurdic, P., Sylla, B. S.
(2006). A nuclear export signal and phosphorylation regulate dok1 subcellular localization and functions.. Mol. Cell. Biol.
26: 4288-4301
[Abstract]
[Full Text]
-
Zhao, M., Janas, J. A., Niki, M., Pandolfi, P. P., Van Aelst, L.
(2006). Dok-1 Independently Attenuates Ras/Mitogen-Activated Protein Kinase and Src/c-Myc Pathways To Inhibit Platelet-Derived Growth Factor-Induced Mitogenesis.. Mol. Cell. Biol.
26: 2479-2489
[Abstract]
[Full Text]
-
Honma, M., Higuchi, O., Shirakata, M., Yasuda, T., Shibuya, H., Iemura, S.-i., Natsume, T., Yamanashi, Y.
(2006). Dok-3 sequesters Grb2 and inhibits the Ras-Erk pathway downstream of protein-tyrosine kinases. GENES CELLS
11: 143-151
[Abstract]
[Full Text]
-
Biswas, R., Stein, D., Stanley, E. R.
(2006). Drosophila Dok is required for embryonic dorsal closure. Development
133: 217-227
[Abstract]
[Full Text]
-
Nakagawa, R., Soh, J. W., Michie, A. M.
(2006). Subversion of Protein Kinase C{alpha} Signaling in Hematopoietic Progenitor Cells Results in the Generation of a B-Cell Chronic Lymphocytic Leukemia-Like Population In vivo. Cancer Res.
66: 527-534
[Abstract]
[Full Text]
-
Boulay, I., Nemorin, J.-G., Duplay, P.
(2005). Phosphotyrosine Binding-Mediated Oligomerization of Downstream of Tyrosine Kinase (Dok)-1 and Dok-2 Is Involved in CD2-Induced Dok Phosphorylation. J. Immunol.
175: 4483-4489
[Abstract]
[Full Text]